Exact Mass: 540.1332
Exact Mass Matches: 540.1332
Found 32 metabolites which its exact mass value is equals to given mass value 540.1332,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Pilaralisib
2-amino-N-[3-({3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-2-methylpropanamide
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
6-O-[(6-O-malonyl)-beta-D-glucopyranosyl]-5-hydroxy-7-phenyl-3H-benzo[de]isochromen-1-one
6-O-[(6-O-malonyl)-beta-D-glucopyranosyl]-5-hydroxy-7-phenyl-3H-benzo[de]isochromen-1-one
6-O-[(6-O-allophanyl)-beta-D-glucopyranosyl]-5-hydroxy-7-phenyl-3H-benzo[de]isochromen-1-one
6-O-[(6-O-allophanyl)-beta-D-glucopyranosyl]-5-hydroxy-7-phenyl-3H-benzo[de]isochromen-1-one
debromosceptrin|debromosceptrin acetate|monobromosceptrin
debromosceptrin|debromosceptrin acetate|monobromosceptrin
(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(methylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol
(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(methylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol
Garenoxacin Mesylate
Garenoxacin Mesylate
C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic
Oxytetracycline, disodium salt, dihydrate
Oxytetracycline, disodium salt, dihydrate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents
Acriflavine (hydrochloride)
Acriflavine (hydrochloride)
Acriflavine hydrochloride (Acriflavinium chloride hydrochloride) is a fluorescent acridine dye that can be used to label nucleic acid[1][2]. Acriflavine hydrochloride is an antiseptic. Acriflavine hydrochloride is a potent HIF-1 inhibitor, with antitumor activity. Acriflavine hydrochloride has antimicrobial and antiviral activities[3][4][5]. Acriflavine hydrochloride is a potent papain-like protease (PLpro) inhibitor, which inhibits SARS-CoV-2[6]
(1's,2r,3r,8'r,10's,11'r,14'r)-10',11',14'-trihydroxy-6,7-dimethoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione
(1's,2r,3r,8'r,10's,11'r,14'r)-10',11',14'-trihydroxy-6,7-dimethoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione
(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-{[(9s)-2,4,5,9-tetrahydroxy-7-methyl-10-oxoanthracen-9-yl]oxy}oxan-2-yl benzoate
(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-{[(9s)-2,4,5,9-tetrahydroxy-7-methyl-10-oxoanthracen-9-yl]oxy}oxan-2-yl benzoate
10-(6-acetyl-7-hydroxy-5-methyl-1,4-dioxonaphthalen-2-yl)-3,8-dihydroxy-1,7,10-trimethyl-9-oxoanthracene-2-carboxylic acid
10-(6-acetyl-7-hydroxy-5-methyl-1,4-dioxonaphthalen-2-yl)-3,8-dihydroxy-1,7,10-trimethyl-9-oxoanthracene-2-carboxylic acid
(5s,6s,12s)-6-(2,4-dihydroxybenzoyl)-8-hydroxy-12-(4-hydroxyphenyl)-5-(4-methoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-10-one
(5s,6s,12s)-6-(2,4-dihydroxybenzoyl)-8-hydroxy-12-(4-hydroxyphenyl)-5-(4-methoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-10-one
7-hydroxy-10-phenyl-8-[(3,4,5-trihydroxy-6-{[hydroxy(c-hydroxycarbonimidoylimino)methoxy]methyl}oxan-2-yl)oxy]-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-2-one
7-hydroxy-10-phenyl-8-[(3,4,5-trihydroxy-6-{[hydroxy(c-hydroxycarbonimidoylimino)methoxy]methyl}oxan-2-yl)oxy]-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-2-one
7-hydroxy-10-phenyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[hydroxy(c-hydroxycarbonimidoylimino)methoxy]methyl}oxan-2-yl]oxy}-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-2-one
7-hydroxy-10-phenyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-{[hydroxy(c-hydroxycarbonimidoylimino)methoxy]methyl}oxan-2-yl]oxy}-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaen-2-one
6-{3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl}-3-(3,4-dihydroxyphenyl)-8-hydroxy-7-oxobicyclo[2.2.2]oct-5-ene-2-carboxylic acid
6-{3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl}-3-(3,4-dihydroxyphenyl)-8-hydroxy-7-oxobicyclo[2.2.2]oct-5-ene-2-carboxylic acid
3,4,5-trihydroxy-6-[(2,4,5,9-tetrahydroxy-7-methyl-10-oxoanthracen-9-yl)oxy]oxan-2-yl benzoate
3,4,5-trihydroxy-6-[(2,4,5,9-tetrahydroxy-7-methyl-10-oxoanthracen-9-yl)oxy]oxan-2-yl benzoate
10',11',14'-trihydroxy-6,7-dimethoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione
10',11',14'-trihydroxy-6,7-dimethoxy-6'-methyl-3,8'-bis(methylsulfanyl)-3h-2'-oxa-3',6'-diazaspiro[1-benzofuran-2,5'-tricyclo[8.4.0.0³,⁸]tetradecan]-12'-ene-4',7'-dione
(1r,2r,3s,4r,8r)-6-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-3-(3,4-dihydroxyphenyl)-8-hydroxy-7-oxobicyclo[2.2.2]oct-5-ene-2-carboxylic acid
(1r,2r,3s,4r,8r)-6-[(1e)-3-[(1r)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-en-1-yl]-3-(3,4-dihydroxyphenyl)-8-hydroxy-7-oxobicyclo[2.2.2]oct-5-ene-2-carboxylic acid
(1r,3s)-5-(1,8-dihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-10-hydroxy-7-methoxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-6,9-dione
(1r,3s)-5-(1,8-dihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-10-hydroxy-7-methoxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-6,9-dione
n-{[2,3-bis(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-4-bromo-1h-pyrrole-2-carboxamide
n-{[2,3-bis(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-4-bromo-1h-pyrrole-2-carboxamide
(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-{[(9r)-2,4,5,9-tetrahydroxy-7-methyl-10-oxoanthracen-9-yl]oxy}oxan-2-yl benzoate
(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-{[(9r)-2,4,5,9-tetrahydroxy-7-methyl-10-oxoanthracen-9-yl]oxy}oxan-2-yl benzoate
(5s,6s)-6-(2,4-dihydroxybenzoyl)-8-hydroxy-12-(4-hydroxyphenyl)-5-(4-methoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-10-one
(5s,6s)-6-(2,4-dihydroxybenzoyl)-8-hydroxy-12-(4-hydroxyphenyl)-5-(4-methoxyphenyl)-4,13-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-trien-10-one
n-{[(1r,2s,3s,4r)-2,3-bis(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-4-bromo-1h-pyrrole-2-carboxamide
n-{[(1r,2s,3s,4r)-2,3-bis(2-imino-1,3-dihydroimidazol-4-yl)-4-[(1h-pyrrol-2-ylformamido)methyl]cyclobutyl]methyl}-4-bromo-1h-pyrrole-2-carboxamide
4-{4-[3-(acetyloxy)-4-hydroxy-6-methoxy-2-methylbenzoyloxy]-2-hydroxy-6-methylbenzoyloxy}-2-hydroxy-6-methylbenzoic acid
4-{4-[3-(acetyloxy)-4-hydroxy-6-methoxy-2-methylbenzoyloxy]-2-hydroxy-6-methylbenzoyloxy}-2-hydroxy-6-methylbenzoic acid
5-(1,8-dihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-10-hydroxy-7-methoxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-6,9-dione
5-(1,8-dihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-10-hydroxy-7-methoxy-1,3-dimethyl-1h,3h,4h-naphtho[2,3-c]pyran-6,9-dione
